4//SEC Filing
Wallace Owen B. 4
Accession 0000899243-22-008681
CIK 0001826457other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:32 PM ET
Size
5.4 KB
Accession
0000899243-22-008681
Insider Transaction Report
Form 4
Wallace Owen B.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+117,450→ 117,450 totalExercise: $13.41Exp: 2032-02-29→ Common Stock (117,450 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001778843
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:32 PM ET
- Size
- 5.4 KB